## Organophosphate Poisoning and Synaptic Dysfunction ### Mechanism of Toxicity **Key Point:** Organophosphates irreversibly inhibit acetylcholinesterase (AChE), the enzyme responsible for breaking down acetylcholine. This leads to massive accumulation of acetylcholine at both the neuromuscular junction and autonomic synapses, causing overstimulation of nicotinic and muscarinic receptors. ### Pathophysiology of Organophosphate Poisoning ```mermaid flowchart TD A[Organophosphate exposure]:::outcome --> B[Irreversible AChE inhibition]:::action B --> C[Acetylcholine accumulation<br/>at synapses]:::action C --> D{Receptor overstimulation}:::decision D -->|Nicotinic effects<br/>NMJ| E[Muscle fasciculations<br/>Paralysis]:::urgent D -->|Muscarinic effects<br/>Autonomic| F[Salivation, lacrimation<br/>Bronchospasm, bradycardia]:::urgent E --> G[Respiratory failure]:::urgent F --> G ``` ### Clinical Features Explained by Acetylcholine Excess | Clinical Sign | Receptor Type | Mechanism | |---------------|---------------|----------| | Muscle fasciculations | Nicotinic (NMJ) | Uncontrolled depolarization from acetylcholine excess | | Flaccid paralysis | Nicotinic (NMJ) | Depolarization block: sustained depolarization prevents repolarization and action potential generation | | Salivation, lacrimation | Muscarinic | Excessive parasympathomimetic stimulation | | Bronchospasm | Muscarinic | Smooth muscle contraction in bronchi | | Bradycardia | Muscarinic | Excessive vagal stimulation of the SA node | | Pinpoint pupils (miosis) | Muscarinic | Ciliary muscle and iris sphincter contraction | | Diarrhea, urinary incontinence | Muscarinic | GI and urinary smooth muscle overstimulation | **High-Yield:** Remember the **SLUDGE mnemonic** for acute cholinergic excess: - **S**alivation - **L**acrimation - **U**rination - **D**efecation - **G**astrointestinal upset - **E**mesis Plus **muscle fasciculations and paralysis** (nicotinic effects). ### Why Irreversible Inhibition Matters **Clinical Pearl:** Organophosphates form a covalent bond with the serine residue in the active site of AChE. Unlike reversible inhibitors (e.g., physostigmine), this bond cannot be broken by simple dissociation. Over time, the enzyme-inhibitor complex undergoes "aging"—loss of an alkyl group—making it truly irreversible. Treatment with pralidoxime (2-PAM) works only if given *before* aging occurs (typically within 24–48 hours). ### Treatment Approach 1. **Atropine**: Muscarinic antagonist (blocks parasympathomimetic effects like bronchospasm, bradycardia, salivation) 2. **Pralidoxime (2-PAM)**: Reactivates AChE by removing the phosphoryl group (only effective before aging) 3. **Benzodiazepines**: Control seizures from nicotinic overstimulation 4. **Supportive care**: Mechanical ventilation for respiratory failure
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.